2025 fourth_quarter Filing

Implementation of P.L. 111-31, the Tobacco Control Act; Issues surrounding FDA PMTA and MRTP compliance policies; Issues surrounding tobacco harm reduction; Issues surrounding efforts to prevent youth access to tobacco products; Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes; Issues surrounding increased scrutiny on FDA/CTP for delayed enforcement; Issues surrounding CBP resources for interdicting massive influx & mislabeling illicit vapes; Issues surrounding retail inspections enforcement limitation; Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act; NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes; January 2025 Proposed Rule: Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products; Issues surrounding efforts to prevent youth access to tobacco products; Discussions regarding federal excise taxes and the taxation of tobacco products; Discussions regarding FDA enforcement of flavored disposable e-cigarettes and PMTA transparency.

Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs); HR 1, THE ONE BIG BEAUTIFUL BILL